HIMS’ forward 12-month P/S of 3.2X is lower than the industry’s average of 5X but is higher than its five-year median of 2.5X. There is no denying that Hims & Hers sits favorably in terms of ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

You’ll need a prescription to purchase this product. Unlike Keeps, Hims allows you to choose between a monthly and a 3-month subscription. Prices start at $22 for a 1-month supply. If you would ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $37.07, along ...

Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term gains from the stock of late. Shares of the San Francisco, CA-based health and wellness platform have surged 156. ...

Citigroup reiterated their sell rating on shares of Hims & Hers Health (NYSE:HIMS – Free Report) in a research report report published on Thursday,Benzinga reports. They currently have a $27.00 price ...

Two major developments of HIMS in recent months include the announcement of ... (reflecting an uptick of 87-94% year over year) and $2.3 billion to $2.4 billion (representing growth of 56-63% ...